<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.napwa.org.au" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>elvitegravir (GS-9137)</title>
 <link>http://www.napwa.org.au/articles-by-tx/450</link>
 <description>Embedded view for the TXinfo ctype</description>
 <language>en-au</language>
<item>
 <title>New treatment briefs</title>
 <link>http://www.napwa.org.au/pl/2011/09/new-treatment-briefs</link>
 <description> &lt;p&gt;Adrian Ogier gives the low-down on latest &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/122&quot;&gt;&lt;span&gt;antiretroviral&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A medication or other substance which is active against retroviruses such as HIV.&lt;/span&gt; treatments.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2011/09/new-treatment-briefs&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/darunavir">darunavir</category>
 <category domain="http://www.napwa.org.au/elvitegravir">Elvitegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/etravirine">etravirine</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/265">news</category>
 <enclosure url="http://www.napwa.org.au/image/view/2757/preview" length="146333" type="image/jpeg" />
 <pubDate>Wed, 31 Aug 2011 23:30:02 -0700</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">2732 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>AIDS 2008: Is the HIV drug pipeline drying up?</title>
 <link>http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up</link>
 <description> &lt;p&gt;The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-&lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/109&quot;&gt;&lt;span&gt;resistant&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;HIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.&lt;/span&gt; HIV, all of which are now available in Australia.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <enclosure url="http://www.napwa.org.au/image/view/868/preview" length="16012" type="image/jpeg" />
 <pubDate>Tue, 23 Sep 2008 19:21:56 -0700</pubDate>
 <dc:creator>David Menadue</dc:creator>
 <guid isPermaLink="false">869 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>CROI 2007: A great leap forward</title>
 <link>http://www.napwa.org.au/pl/2007/03/croi-2007-a-great-leap-forward</link>
 <description> &lt;p&gt;A major scientific conference on HIV has wound up with promising news on treatments which could signal a significant improvement in HIV treatment for the first time in some years.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2007/03/croi-2007-a-great-leap-forward&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/cancers/anal-cancer">anal cancer</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nnrtis/efavirenz">efavirenz</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/heart-disease">heart disease</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/lopinavir">lopinavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <enclosure url="http://www.napwa.org.au/image/view/785/preview" length="10736" type="image/jpeg" />
 <pubDate>Wed, 21 Mar 2007 07:10:12 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">606 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Rocky Mountain CROI</title>
 <link>http://www.napwa.org.au/pl/2006/04/rocky-mountain-croi</link>
 <description> &lt;p&gt;The 13th annual Conference on Retroviruses and Opportunistic Infections (&lt;span class=&quot;caps&quot;&gt;CROI&lt;/span&gt;) took place in Denver, Colorado, from February 5 to 8. The major breaking news from this conference was the premature cancellation of the &lt;span class=&quot;caps&quot;&gt;SMART&lt;/span&gt; study, but as usual, this important conference produced a great deal more than a single story.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2006/04/rocky-mountain-croi&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/heart-disease">heart disease</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/hepatitis-c">hepatitis C</category>
 <category domain="http://www.napwa.org.au/living-with-hiv/defeating-hiv/sex-and-relationships/hiv-prevention/pre-exposure-prophylaxis-prep">Pre-exposure prophylaxis (PrEP)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/multi-class-formulations/truvada">Truvada</category>
 <enclosure url="http://www.napwa.org.au/image/view/1306/preview" length="34082" type="image/jpeg" />
 <pubDate>Wed, 26 Apr 2006 07:08:00 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">543 at http://www.napwa.org.au</guid>
</item>
</channel>
</rss>

